MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

Perrigo Co PLC

Chiusa

SettoreSettore sanitario

26.93 -0.85

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

26.82

Massimo

27.21

Metriche Chiave

By Trading Economics

Entrata

38M

-6.4M

Vendite

-94M

1B

Rendimento da dividendi

4.34

Margine di Profitto

-0.613

Dipendenti

8,379

EBITDA

13M

127M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+26.15% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

4.34%

2.42%

Utili prossimi

1 ago 2025

Prossima data del Dividendo

16 set 2025

Prossima data del' Ex Dividendo

29 ago 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

414M

3.8B

Apertura precedente

27.78

Chiusura precedente

26.93

Notizie sul Sentiment di mercato

By Acuity

46%

54%

147 / 376 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

Perrigo Co PLC Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

14 lug 2025, 13:01 UTC

Acquisizioni, Fusioni, Takeovers

Perrigo to Sell Dermacosmetics Business to KKR With Focus on Streamlining Company

28 feb 2025, 17:42 UTC

I principali Market Mover

Perrigo Shares Jump on FDA's Move to Reclassify Wisconsin Infant-Formula Plant

27 feb 2025, 23:52 UTC

Utili

Perrigo Gets Facility Reclassification From FDA as 4Q Profit, Revenue Fall

14 lug 2025, 12:33 UTC

Acquisizioni, Fusioni, Takeovers

Perrigo: Business Generated About 5% of 2024 Adjusted Operating Income >PRGO

14 lug 2025, 12:33 UTC

Acquisizioni, Fusioni, Takeovers

Perrigo: Dermacosmetics Branded Business Generated About EUR125 Million Sales in 2024 >PRGO

14 lug 2025, 12:32 UTC

Acquisizioni, Fusioni, Takeovers

Perrigo: Deal Proceeds to Further Strengthen Balance Sheet >PRGO

14 lug 2025, 12:31 UTC

Acquisizioni, Fusioni, Takeovers

Perrigo: Deal Includes EUR300 Million Upfront Cash, Up to EUR27 Million Contingent Payments >PRGO

14 lug 2025, 12:31 UTC

Acquisizioni, Fusioni, Takeovers

Perrigo To Sell Dermacosmetics Branded Business to KKR Investment Vehicle >PRGO

14 lug 2025, 12:30 UTC

Acquisizioni, Fusioni, Takeovers

Perrigo Announces Agreement to Divest Dermacosmetics Business for Up to EUR327 Million

Confronto tra pari

Modifica del prezzo

Perrigo Co PLC Previsione

Obiettivo di Prezzo

By TipRanks

26.15% in crescita

Previsioni per 12 mesi

Media 34.25 USD  26.15%

Alto 42 USD

Basso 27 USD

Basato su 4 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Perrigo Co PLC - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

4 ratings

2

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

25.22 / 26.85Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Strong Bullish Evidence

A lungo termine

Bullish Evidence

Sentiment

By Acuity

147 / 376 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Perrigo Co PLC

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. It also offers healthy lifestyle products, such as smoking cessation, well-being, and weight management products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; rare diseases business; and other miscellaneous self-care products. The company sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, Compeed Stops, XLS, Arterin, Davitamon, Apiserum, Abtei, and Nicorette brands. It also offers contract manufacturing services. The company sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.